These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26999168)

  • 1. An Evaluation of the Efficacy of Selective Alpha-Blockers in the Treatment of Children with Neurogenic Bladder Dysfunction--Preliminary Findings.
    Kroll P; Gajewska E; Zachwieja J; Sobieska M; Mańkowski P
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26999168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha blocker therapy for children with dysfunctional voiding and urinary retention.
    Cain MP; Wu SD; Austin PF; Herndon CD; Rink RC
    J Urol; 2003 Oct; 170(4 Pt 2):1514-5; discussion 1516-7. PubMed ID: 14501648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of alpha1-adrenergic blockers in boys with low urinary flow rate and urinary incontinence.
    Yang SS; Wang CC; Chen YT
    J Formos Med Assoc; 2003 Aug; 102(8):551-5. PubMed ID: 14569320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of toxin-A Botulinum for treating intractable bladder hyperactivity in children affected by neuropathic bladder secondary to myelomeningocele: an alternative to enterocystoplasty].
    Marte A; Vessella A; Cautiero P; Romano M; Borrelli M; Noviello C; Del Gado R; Parmeggiani P
    Minerva Pediatr; 2005 Feb; 57(1):35-40. PubMed ID: 15791200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can alpha-blocker therapy be an alternative to biofeedback for dysfunctional voiding and urinary retention? A prospective study.
    Yucel S; Akkaya E; Guntekin E; Kukul E; Akman S; Melikoglu M; Baykara M
    J Urol; 2005 Oct; 174(4 Pt 2):1612-5; discussion 1615. PubMed ID: 16148665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of onabotulinumtoxinA treatment on symptoms and urodynamic findings in pediatric neurogenic bladder.
    Kask M; Rintala R; Taskinen S
    J Pediatr Urol; 2014 Apr; 10(2):280-3. PubMed ID: 24095686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction.
    Austin PF; Homsy YL; Masel JL; Cain MP; Casale AJ; Rink RC
    J Urol; 1999 Sep; 162(3 Pt 2):1064-7. PubMed ID: 10458432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women.
    Serels S; Stein M
    Neurourol Urodyn; 1998; 17(1):31-6. PubMed ID: 9453690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
    Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
    Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic parameters development and complications of clean intermittent self-catheterization in Chinese schoolchildren with neurogenic underactive bladder.
    Wang QW; Song DK; Zhang XP; Wu YD; Zhang RL; Wei JX; Wen JG
    Urol Int; 2011; 86(4):461-5. PubMed ID: 21555862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alfuzosin in the treatment of high leak-point pressure in children with neurogenic bladder.
    Schulte-Baukloh H; Michael T; Miller K; Knispel HH
    BJU Int; 2002 Nov; 90(7):716-20. PubMed ID: 12410754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind placebo controlled study of alpha-adrenergic receptor antagonists (doxazosin) for treatment of voiding dysfunction in the pediatric population.
    Kramer SA; Rathbun SR; Elkins D; Karnes RJ; Husmann DA
    J Urol; 2005 Jun; 173(6):2121-4; discussion 2124. PubMed ID: 15879863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary continence outcome after augmentation ileocystoplasty as a single surgical procedure in patients with myelodysplasia.
    Medel R; Ruarte AC; Herrera M; Castera R; Podesta ML
    J Urol; 2002 Oct; 168(4 Pt 2):1849-52. PubMed ID: 12352374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of paediatric neurogenic bladder: an approach in a resource-poor setting.
    Maison POM; Lazarus J
    Paediatr Int Child Health; 2017 Nov; 37(4):280-285. PubMed ID: 28714784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurogenic bladder: urodynamic and surgical aspects.
    Kataria R; Bajpai M; Lall A; Gupta DK; Grover VP; Mitra DK
    Indian J Pediatr; 1997; 64(6 Suppl):68-76. PubMed ID: 11129884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination of drugs and clean intermittent catheterization in the treatment of neurogenic bladder. Effect on continence].
    Jiménez J; Arruebarrena D; Rodríguez J; Urbieta MA; Arriola M; Aresès R
    An Esp Pediatr; 1987 Nov; 27(5):343-6. PubMed ID: 3439656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of neurogenic bladder dysfunction secondary to myelomeningocele.
    Castro-Gago M; Novo I; Cimadevila A; Peña J; Rodriguez-Núñez A; Marqués'-Queimadelos A
    Eur J Pediatr; 1990 Nov; 150(1):62-5. PubMed ID: 2079080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin injection in the pediatric population with medically refractory neuropathic bladder.
    Khan MK; VanderBrink BA; DeFoor WR; Minevich E; Jackson E; Noh P; Reddy PP
    J Pediatr Urol; 2016 Apr; 12(2):104.e1-6. PubMed ID: 26778185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The comparative study on selective alpha1-blocker and behavioural therapy in the treatment of discoordinated voiding in children].
    Kroll P; Jankowski A; Maćkowiak J
    Przegl Lek; 2006; 63 Suppl 3():226-8. PubMed ID: 16898538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.